According to ImmunoGen 's latest financial reports the company's total assets are S$1.04 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | S$0.46 B | -34.19% |
2021-12-31 | S$0.71 B | 51.32% |
2020-12-31 | S$0.46 B | 48.1% |
2019-12-31 | S$0.31 B | -21.4% |
2018-12-31 | S$0.40 B | 2.39% |
2017-12-31 | S$0.39 B | |
2016-06-30 | S$0.37 B | -9.43% |
2015-06-30 | S$0.41 B | 101.52% |
2014-06-30 | S$0.20 B | -23.96% |
2013-06-30 | S$0.27 B | 18.64% |
2012-06-30 | S$0.22 B | -14.46% |
2011-06-30 | S$0.26 B | 40.18% |
2010-06-30 | S$0.19 B | 30.98% |
2009-06-30 | S$0.14 B | 28.26% |
2008-06-30 | S$0.11 B | -8.06% |
2007-06-30 | S$0.12 B | -17.66% |
2006-06-30 | S$0.14 B | -19.66% |
2005-06-30 | S$0.18 B | -11.29% |
2004-06-30 | S$0.21 B | 1.44% |
2003-06-30 | S$0.20 B | -22.94% |
2002-06-30 | S$0.26 B | -7.29% |
2001-06-30 | S$0.29 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Seagen
SGEN | S$4.63 B | 342.07% | ๐บ๐ธ USA |
![]() Amgen AMGN | S$113.85 B | 10,770.56% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | S$113.88 B | 10,773.21% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | S$117.75 B | 11,142.78% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | S$246.73 B | 23,458.05% | ๐บ๐ธ USA |
![]() Pfizer PFE | S$265.02 B | 25,204.43% | ๐บ๐ธ USA |
![]() Novartis NVS | S$127.32 B | 12,056.78% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | S$181.78 B | 17,256.99% | ๐ซ๐ท France |